Assignee
NAPAJEN PHARMA INC
US·1 granted patent·5 pending applications·5 citations·filing 2017–2021
Top patents by PatentIndex Score
6 records- 0181US11203755B2Chemically-modified siRNANAPAJEN PHARMA INC·Filed 2017·Granted Dec 21, 2021·5 cites·24 claims
- 0255US2023365966A1Homogeneous beta-1,3-glucan/nucleic acid complexes and use thereofNAPAJEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0351US2023053708A1Short-chain cpg-containing oligodeoxynucleotide with linked polydeoxyadenylic acid, complex containing said oligodeoxynucleotide, and use thereofNAPAJEN PHARMA INC·Filed 2020·Application pending·0 cites
- 0443US2021154309A1PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF CHEMICALLY-MODIFIED siRNA AND SCHIZOPHYLLANNAPAJEN PHARMA INC·Filed 2019·Application pending·0 cites
- 0538US2020038428A1Cancer cell adhesion activity inhibitorNAPAJEN PHARMA INC·Filed 2018·Application pending·0 cites
- 0637US2019175728A1Nucleic acid-antigen peptide conjugateNAPAJEN PHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAPAJEN PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →